Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...

A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Danish asset manager Novo Holdings, which is owned by Novo Nordisk Foundation (NNF), the majority voting shareholder of pharmaceuticals giant Novo Nordisk, is investing in Biocomposites alongside ...

Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management HELLERUP, Denmark, LONDON and KEELE ...

HELLERUP, DENMARK, LONDON and KEELE, UK – 3 March 2025 – Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment ...

A pioneering global manufacturer of brake and clutch components is driving innovation with the support of Bangor University.